CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-591 Cr | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr | ₹-18 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-591 Cr |
| Mar2024 | ₹-403 Cr |
| Mar2023 | ₹-293 Cr |
| Mar2022 | ₹-205 Cr |
| Mar2021 | ₹-18 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-591 Cr | Negative | |
| Mar2024 | ₹-403 Cr | Negative | |
| Mar2023 | ₹-293 Cr | Negative | |
| Mar2022 | ₹-205 Cr | Negative | |
| Mar2021 | ₹-18 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,362.3 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
| MANKIND PHARMA | ₹83,688.0 Cr | -2.6% | -5.6% | -15% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.1% |
-2.2% |
-8.9% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses